【摘要】 目的 探讨子宫部位异位妊娠的临床特征和处理对策。 方法 回顾分析2002年9月-2009年9月间收治的31例子宫部位异位妊娠患者的临床资料。 结果 31例患者中，初诊确诊仅8例，误诊率74.2%。除5例因难以控制的大出血行经腹病灶清除术加子宫修补术或全子宫切除术外，其余26例患者均经氨甲喋呤（MTX）治疗加清宫术或宫腔镜下病灶清除术保守治疗成功。 结论 子宫部位异位妊娠容易误诊，超声检查是诊断的主要方法。保守治疗安全、有效，可保留生育能力。氨甲喋呤治疗加清宫术可作为治疗子宫部位异位妊娠的主要方法。【Abstract】 Objective To investigate the clinical characteristics and treatment of ectopic pregnancy in the uterus. Methods The clinical data of 31 patients diagnosed as ectopic pregnancy from September 2002 to September 2009 were analyzed retrospectively. Results During preliminary diagnosis, only eight patients were accurately diagnosed.The error rate of first diagnosis was 74.2%. Five patients suffered focal cleaning and uterus neoplasty or total hysterectomy due to uncontrollable bleeding.The other 26 patients were successfully cured by conservation treatment of methotrexate (MTX) combined with dilatation and curettage or clearance of focal lesion under hysteroscopy. Conclusion Misdiagnosis of ectopic pregnancy in the uterus is easy to make.The ultrasonography is the main method for the diagnosis of ectopic pregnancy in the uterus.Conservative treatment is proved to be safe and effective and can preserve the patients’ fertility. Administration of MTX combined with dilatation and curettage is an main therapeutic method in handling ectopic pregnancy in the uterus.
目的:探讨超声在异位妊娠中的诊断及鉴别诊断价值。方法:回顾性分析我院超声诊断45例异位妊娠,并与手术及病理检查结果进行对照。结果:经超声诊断异位妊娠正确率达88.9%(40/45)。结论:超声对异位妊娠的诊断和鉴别诊断均具有较好的临床价值。
【摘要】 目的 探讨甲氨蝶呤(MTX)联合米非司酮治疗早期异位妊娠(EP)的临床效果。 方法 收集2006年2月-2010年2月收治的早期未破裂型EP患者126例，随机分为MTX联合米非司酮组62例，单独应用MTX组64例， MTX治疗采用小剂量分次肌肉注射给药进行。 结果 126例患者中，MTX联合米非司酮组和单独应用MTX治疗组的成功率为分别为88%和65%，两组差异有统计学意义(Plt;0.05)。 结论 MTX小剂量分次给药联合米非司酮治疗早期未破裂型EP效果优于MTX的单独使用。【Abstract】 Objective To observe the therapeutic effect of methotrexate (MTX) combined with mifepristone on early ectopic pregnancy. Methods A total of 126 patients with early ectopic pregnancy diagnosed from February 2006 to Febrary 2010 were randomly divided into two groups. In 126 patients, 62 treated with MTX combined with mifepristone were in the treatment group,and 64 treated independently with MTX were in the control group. MTX was administrated at a low dose in several times. Results In 126 patients,the success ratio of the treatment was 88% in treatment group groups and 65% in the control group; the difference between the two groups was significant (Plt;0.05). Conclusion Low-dose MTX in separate times combined with mifepriston is effective on the early ectopic pregnancy, and the therapeutic effect of the combined administration of MTX and mifepriston is better than that of the single administration with MTX.
目的:探讨米非司酮治疗异位妊娠的疗效,安全性及对患者生育的影响。方法:选取符合保守治疗条件患者31例,观察米非司酮治疗异位妊娠过程中的临床症状,各项试验室指标的变化;出现不良反应的几率及严重程度;治疗后输卵管的通畅情况,以判断是否对患者生育造成影响。结果:治疗成功率为87.09%;不良反应出现率为19.35%,均为轻度不适;成功病例中未育患者输卵管通畅率为100%。结论:米非司酮是一种治疗异位妊娠的高效药物,具有安全性高,不良反应少,对生育无影响的优点。
目的：分析我院近10年来异位妊娠发生率、发病年龄、诊断和治疗。方法：以5年为一个时间段回顾分析我院1997年1月至2006年12月异位妊娠发生率、发病年龄、诊断和治疗。结果：我院1997年1月至2006年12月共收治异位妊娠740例。异位妊娠数与同期宫内妊娠数之比，由1997年1月至2001年12月的1∶23.99上升为2002年1月至2006年12月的1∶11.60（P＜0.01）。≤25岁异位妊娠的发病率由1997年至2001年的14.7%上升到2002年至2006年的289%，其中≤20岁妇女及合并不孕者有增多趋势。异位妊娠的早期诊断率增高，发生异位妊娠破裂者由1997年至2001年的120例（45.3%）下降至2002年至2006年的85例（17.9%）（P＜0.01）。经腹行输卵管切除仍为主要治疗手段，但腹腔镜手术及保守性手术逐渐增多，非手术治疗明显增多。结论：异位妊娠发生率呈上升趋势，发病年龄年轻化，近年早期诊断率增高，减少误诊及异位妊娠破裂发生，经腹手术仍为主要治疗手段，但腹腔镜和保守治疗上升。
Objective To compare the surgical outcome and investigate the clinic value between laparoscopic operation and laparotomy in the treatment of ectopic pregnancy. Methods We searched PubMed, EMbase, SCI, The Cochrane Library, Chinese Biomedical Literature Database, China Journal Full Text Database, Chinese Medical Association Journals, and references of the included studies up to April 2009. Studies involving treatment outcome of ectopic pregnancy using laparoscopy compared with laparotomy were included. Data were extracted and methodological quality were evaluated by two reviewers independently with designed extraction form. The Cochrane Collaboration’s RevMan 5.0.1 software was used for data analyses. Results A total of 11 studies involving 1795 patients were included. The results of meta-analyses showed that laparoscopy comparing with laparotomy; the operation time and complications had no difference; intraoperative blood loss was less than laparotomy; intestinal gas exhaust and evacuation active time was earlier than laparotomy. Conclusion Laparoscopy treating for ectopic pregnancy is better than laparotomy. It is a minimally invasive surgical technique, and is worthy to be popularized.
Objective To analyze the effectiveness of conservative medical treatments for ectopic pregnancy (EP): methotrexate (MTX) + mifepristone + Ectopic Pregnancy II decoction (EP-II) vs. methotrexate + mifepristone. Methods A total of 95 patients with EP in Shenzhen Shajing Affiliated Hospital of Guangzhou Medical University from January 2009 to January 2011 were randomly divided into two groups: 45 patients in the experimental group were treated with MTX, mifepristone and EP II decoction, while the other 50 patients in the control group were treated with MTX and mifepristone. The effectiveness of the two groups was analyzed with SPSS 13.0 software. Results There were significant differences in the time of serum β-HCG return to normal (16.13±8.13 ds vs. 22.05±7.15 ds, Plt;0.05), time of EP mass absorption (30.46±7.56 ds vs. 39.99±18.26 ds, Plt;0.05) and tubal patency rate (80% vs. 75%, Plt;0.05) between the two groups. But there were no significant differences in effective rate (95.56%, 43/45 vs. 94%, 47/50, χ2=0.0809, Pgt;0.05) and side effects. Conclusion The combination of methotrexate, mifepristone and EP II decoction for ectopic pregnancy is more effective than mifepristone and methotrexate in coordinately killing the embryo, shortening the time of serum β-HCG return to normal and the time of EP mass absorption, and improving the function of oviducts.